Company intelligence / Profile preview

Dionymer

Mérignac, Nouvelle-Aquitaine, Francedionymer.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Dionymer has developed a unique bacterial fermentation platform that converts food and other organic waste into high-performance, biodegradable polyhydroxyalkanoate (PHA) polymers. These biopolymers serve as sustainable alternatives to petroleum-based plastics across multiple industries including packaging, cosmetics, textiles, and agriculture. The company’s approach addresses both environmental impact reduction and circular economy goals by valorizing waste streams.

Modalities: Biodegradable polymerPolyhydroxyalkanoates (PHA)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Dionymer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dionymer.

Explore the full profile